Why Was The World-Wide Vaccine industry So Panicked Over The Geiers Addressing the UNEP Meeting in Japan?

[Guest guest]

Why Was The World-Wide Vaccine industry So Panicked Over The Geiers

Addressing the UNEP Meeting in Japan?

Opinion by Consumer Advocate Tim Bolen

Tuesday, May 24th, 2011

According to the authoritative source, VaccineEthics.org:

" Virtually all licensed vaccines in the United States are produced

by

just a handful of pharmaceutical companies: GlaxoKline, Merck,

Novartis, Sanofi Pasteur, and Wyeth. These companies account for 80

percent of the worldwide vaccine market.1 With a limited number of

manufacturers and many recommended vaccines produced by only a

single

company, vaccines are susceptible to large fluctuations in supply

and

availability.2

Thirty years ago, the vaccine market looked remarkably different. At

the time, 35 companies produced vaccines for use in the United

States, and similar departures from the international vaccine market

have also occurred in the intervening years. Between 1988 and 2001,

10 of 14 global vaccine manufactures partially or completely stopped

production of traditional childhood vaccines.3 Health policy experts

and economists attribute this trend primarily to market and

financial

considerations--namely, sparse profits; costly research, development

and production; and liability concerns. "

They go on to say several other important things, explaining how the

vaccine industry works. In short, the industry is completely

dependant on government protection from lawsuits. More, governments

are the biggest buyers of vaccines. VaccineEthics.org says:

" Meanwhile, the largest single purchasers of vaccines are

governments. In the U.S., for example, the federal and state

branches

constitute close to 60 percent of all pediatric vaccines sold in the

country.9 "

This financial landscape means that the vaccine industry is unlikely

to invest in a product that will not both pay for itself and turn a

profit--characteristics which (almost) require a significant demand

in wealthy, developed countries....

Since it is estimated 60 percent of vaccine production costs are

fixed, meaning they are incurred regardless of the amount of product

produced, vaccines require a sizable market to be

profitable. "

To read the entire article click on

http://www.bolenreport.com or

http://www.bolenreport.com/Geier/VaccineIndustryPanics.htm

Tim Bolen

http://www.bolenreport.com

http://www.quackpotwatch.org

--

[Guest guest]

Why Was The World-Wide Vaccine industry So Panicked Over The Geiers

Addressing the UNEP Meeting in Japan?

Opinion by Consumer Advocate Tim Bolen

Tuesday, May 24th, 2011

According to the authoritative source, VaccineEthics.org:

" Virtually all licensed vaccines in the United States are produced

by

just a handful of pharmaceutical companies: GlaxoKline, Merck,

Novartis, Sanofi Pasteur, and Wyeth. These companies account for 80

percent of the worldwide vaccine market.1 With a limited number of

manufacturers and many recommended vaccines produced by only a

single

company, vaccines are susceptible to large fluctuations in supply

and

availability.2

Thirty years ago, the vaccine market looked remarkably different. At

the time, 35 companies produced vaccines for use in the United

States, and similar departures from the international vaccine market

have also occurred in the intervening years. Between 1988 and 2001,

10 of 14 global vaccine manufactures partially or completely stopped

production of traditional childhood vaccines.3 Health policy experts

and economists attribute this trend primarily to market and

financial

considerations--namely, sparse profits; costly research, development

and production; and liability concerns. "

They go on to say several other important things, explaining how the

vaccine industry works. In short, the industry is completely

dependant on government protection from lawsuits. More, governments

are the biggest buyers of vaccines. VaccineEthics.org says:

" Meanwhile, the largest single purchasers of vaccines are

governments. In the U.S., for example, the federal and state

branches

constitute close to 60 percent of all pediatric vaccines sold in the

country.9 "

This financial landscape means that the vaccine industry is unlikely

to invest in a product that will not both pay for itself and turn a

profit--characteristics which (almost) require a significant demand

in wealthy, developed countries....

Since it is estimated 60 percent of vaccine production costs are

fixed, meaning they are incurred regardless of the amount of product

produced, vaccines require a sizable market to be

profitable. "

To read the entire article click on

http://www.bolenreport.com or

http://www.bolenreport.com/Geier/VaccineIndustryPanics.htm

Tim Bolen

http://www.bolenreport.com

http://www.quackpotwatch.org

--